Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

19
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

31
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
31
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

24
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
24
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

25
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

17
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
17

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic Diversity and Outcomes of Transcatheter Mitral Repair for Secondary Mitral Regurgitation: Insights From the COAPT and MITRA-FR Trials.

JACC. Cardiovascular interventions·2026
Same author

Prognostic utility of the MECKI score in a mixed United States cohort.

Physiological reports·2026
Same author

Synthetic Contrast-Free LGE in Acute MI: Assessing the Promise and Boundaries of Diffusion-Based Modeling.

Circulation. Cardiovascular imaging·2026
Same author

Constrictive pericarditis.

The international journal of cardiovascular imaging·2026
Same author

Identification of Heart Transplant Rejection Subtypes With Circulating MicroRNAs.

Circulation. Heart failure·2026
Same author

Utilization and outcomes of cardiopulmonary resuscitated donor hearts in the modern era.

JTCVS open·2025
Same journal

Giant Coronary Artery Aneurysm Arising From a Septal Perforator: Diagnosis and Percutaneous Management.

JACC. Case reports·2026
Same journal

Magnetic Resonance Imaging and Video-Assisted Thoracoscopy Facilitate the Comprehensive Management of a Large Pericardial Cyst.

JACC. Case reports·2026
Same journal

Refractory Ventricular Fibrillation Associated With a Coronary Vasospasm and Fixed Moderate Coronary Stenosis.

JACC. Case reports·2026
Same journal

Transcatheter Closure of Post-Myocardial Infarction Ventricular Septal Rupture Using an Atrial Septal Defect Occluder.

JACC. Case reports·2026
Same journal

Single-Access Retrieval of a Ruptured Balloon During Balloon-Expandable TAVI.

JACC. Case reports·2026
Same journal

Bilateral Modified Self-Expanding Valve Implantation in Branch Pulmonary Arteries.

JACC. Case reports·2026
See all related articles

Related Experiment Video

Updated: Aug 17, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K

Right Atrial Compression From Biodebris Associated With Long-Term Left Ventricular Assist Device Support.

Sara G Kwiatkowski1, Zachary M Gertz2, John D Grizzard3

  • 1Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.

JACC. Case Reports
|December 12, 2022
PubMed
Summary
This summary is machine-generated.

Biodebris commonly accumulates around the HeartWare Ventricular Assist Device (HVAD) outflow cannula over time. This accumulation can lead to serious complications like right atrial compression in patients requiring long-term support.

Keywords:
CTA, computed tomography angiographyLVAD, left ventricular assist deviceRA, right atriumTTE, transthoracic echocardiogramcardiomyopathychronic heart failuretamponade

More Related Videos

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.4K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

927

Related Experiment Videos

Last Updated: Aug 17, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.4K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

927

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Medical Device Technology

Background:

  • The HeartWare Ventricular Assist Device (HVAD) is a centrifugal-flow left ventricular assist device used for advanced heart failure.
  • Accumulation of biodebris around the device's outflow cannula is a known, yet not fully understood, phenomenon.

Observation:

  • Two patients on long-term HVAD support presented with right atrial compression.
  • The compression was attributed to significant biodebris accumulation around the intrapericardial outflow cannula.

Findings:

  • A review of the institution's HVAD cohort confirmed that biodebris accumulation around the outflow cannula is common.
  • The extent and clinical significance of this biodebris warrant further investigation.

Implications:

  • Understanding biodebris formation is crucial for optimizing long-term ventricular assist device performance and patient safety.
  • This phenomenon may necessitate monitoring strategies or interventions to prevent device-related complications.